Only One ANDA Was Submitted To The US FDA During The Shutdown; It Should Have Been None

The FDA could see a large bolus of ANDA submissions in November because of the government shutdown. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from United States